Teen, family reach settlement for brain injury KOMO Seattle Wed, 16 Sep 2009 18:05 PM PDT Nearly three years ago, Zack Lystedt made a tackle on the football field and suffered a concussion. He was in pain, but coaches put him back in the game. He later collapsed with a brain injury. Lystedt and his family have reached a settlement with the Tahoma School District. | Ravensâ Birk donates brain for safety of future linemen Everett Herald Wed, 16 Sep 2009 17:38 PM PDT OWINGS MILLS, Md. â" Harvard graduate Matt Birk has pledged to donate his brain and spinal cord tissues after death to a Boston University medical school program that studies sports brain injuries. | Drug may reduce hot flashes Straits Times Wed, 16 Sep 2009 17:12 PM PDT BOSTON - A DRUG that prevents premature ovulation during fertility treatments helped reduce the number of hot flashes by up to 80 per cent in a small study of women entering menopause, researchers reported on Wednesday. They said the drug Cetrotide, made by Merck Serono, a subsidiary of the German company Merck, blocked the action of a key brain hormone involved in hot flashes. | Morey: NFL needs to aid brain research East Valley Tribune Wed, 16 Sep 2009 17:11 PM PDT Â No one seems to know with certainty how many concussions players suffer each season in the NFL. For too long, they went unreported and untreated. Too many players simply write them off as an occupational hazard even now. There's still only so much agreement, even among doctors and researchers, about the long-term effects. And all the while, the hits that produce them keep filling up highlight ... | (AFX UK Focus) 2009-09-16 23:04 UPDATE 2-US FDA says no new warnings on Biogen, Elan MS drug Interactive Investor Wed, 16 Sep 2009 15:28 PM PDT WASHINGTON, Sept 16 (Reuters) - A Biogen Idec and Elan Corp multiple sclerosis drug does not need new warnings despite additional reports of a life-threatening brain infection, U.S. regulators said on Wednesday. Thirteen cases of progressive multifocal leukoencephalopathy (PML) have been confirmed through Sept. 8 in MS patients treated with Tysabri as a stand-alone therapy, the Food and Drug ... | | |
|
No comments:
Post a Comment